<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33113845</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>01</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>21</Issue><PubDate><Year>2020</Year><Month>Oct</Month><Day>25</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Heterogeneity of Neuroinflammatory Responses in Amyotrophic Lateral Sclerosis: A Challenge or an Opportunity?</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">7923</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms21217923</ELocationID><Abstract><AbstractText>Amyotrophic Lateral Sclerosis (ALS) is a complex pathology: (i) the neurodegeneration is chronic and progressive; it starts focally in specific central nervous system (CNS) areas and spreads to different districts; (ii) multiple cell types further than motor neurons (i.e., glial/immune system cells) are actively involved in the disease; (iii) both neurosupportive and neurotoxic neuroinflammatory responses were identified. Microglia cells (a key player of neuroinflammation in the CNS) attracted great interest as potential target cell population that could be modulated to counteract disease progression, at least in preclinical ALS models. However, the heterogeneous/multifaceted microglia cell responses occurring in different CNS districts during the disease represent a hurdle for clinical translation of single-drug therapies. To address this issue, over the past ten years, several studies attempted to dissect the complexity of microglia responses in ALS. In this review, we shall summarize these results highlighting how the heterogeneous signature displayed by ALS microglia reflects not only the extent of neuronal demise in different regions of the CNS, but also variable engagement in the attempts to cope with the neuronal damage. We shall discuss novel avenues opened by the advent of single-cell and spatial transcriptomics technologies, underlining the potential for discovery of novel therapeutic targets, as well as more specific diagnostic/prognostic not-invasive markers of neuroinflammation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cipollina</LastName><ForeName>Giada</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, via Ferrata 9, 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davari Serej</LastName><ForeName>Arash</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, via Ferrata 9, 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Nolfi</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, via Ferrata 9, 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gazzano</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, via Ferrata 9, 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marsala</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, via Ferrata 9, 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spatafora</LastName><ForeName>Mauro G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, via Ferrata 9, 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peviani</LastName><ForeName>Marco</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0576-6166</Identifier><AffiliationInfo><Affiliation>Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, via Ferrata 9, 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>17-IIP-343</GrantID><Agency>Amyotrophic Lateral Sclerosis Association</Agency><Country/></Grant><Grant><GrantID>20-IIA-525</GrantID><Agency>Amyotrophic Lateral Sclerosis Association</Agency><Country/></Grant><Grant><GrantID>W81XWH-17-1-0036</GrantID><Agency>U.S. Department of Defense</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018740" MajorTopicYN="Y">Genetic Heterogeneity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059014" MajorTopicYN="N">High-Throughput Nucleotide Sequencing</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">PET</Keyword><Keyword MajorTopicYN="N">microglia</Keyword><Keyword MajorTopicYN="N">neuroinflammation</Keyword><Keyword MajorTopicYN="N">single-cell RNAseq</Keyword><Keyword MajorTopicYN="N">spatial transcriptomics</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>10</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>10</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>29</Day><Hour>1</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33113845</ArticleId><ArticleId IdType="pmc">PMC7662281</ArticleId><ArticleId IdType="doi">10.3390/ijms21217923</ArticleId><ArticleId IdType="pii">ijms21217923</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Silani V. Therapy in Amyotrophic Lateral Sclerosis (ALS): An unexpected evolving scenario. Arch. Ital. Biol. 2017;155:118&#x2013;130.</Citation><ArticleIdList><ArticleId IdType="pubmed">29405033</ArticleId></ArticleIdList></Reference><Reference><Citation>Molteni M., Rossetti C. Neurodegenerative diseases: The immunological perspective. J. Neuroimmunol. 2017;313:109&#x2013;115. doi: 10.1016/j.jneuroim.2017.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2017.11.002</ArticleId><ArticleId IdType="pubmed">29153601</ArticleId></ArticleIdList></Reference><Reference><Citation>Navarro V., Sanchez-Mejias E., Jimenez S., Mu&#xf1;oz-Castro C., Sanchez-Varo R., Davila J.C., Vizuete M., Gutierrez A., Vitorica J. Microglia in Alzheimer&#x2019;s Disease: Activated, Dysfunctional or Degenerative. Front. Aging Neurosci. 2018;10:140. doi: 10.3389/fnagi.2018.00140.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2018.00140</ArticleId><ArticleId IdType="pmc">PMC5958192</ArticleId><ArticleId IdType="pubmed">29867449</ArticleId></ArticleIdList></Reference><Reference><Citation>Brites D., Vaz A.R. Microglia centered pathogenesis in ALS: Insights in cell interconnectivity. Front. Cell. Neurosci. 2014;8:117. doi: 10.3389/fncel.2014.00117.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00117</ArticleId><ArticleId IdType="pmc">PMC4033073</ArticleId><ArticleId IdType="pubmed">24904276</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q., Haney M.S. The role of glia in protein aggregation. Neurobiol. Dis. 2020:143. doi: 10.1016/j.nbd.2020.105015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.105015</ArticleId><ArticleId IdType="pubmed">32663608</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad L.I., Pokrishevsky E., Silverman J.M., Cashman N.R. Exosome-dependent and independent mechanisms are involved in prion-like transmission of propagated Cu/Zn superoxide dismutase misfolding. Prion. 2014;8:331&#x2013;335. doi: 10.4161/19336896.2014.983398.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/19336896.2014.983398</ArticleId><ArticleId IdType="pmc">PMC4601269</ArticleId><ArticleId IdType="pubmed">25551548</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xf6;yh&#xf6;nen S., Er S., Domanskyi A., Airavaara M. Effects of neurotrophic factors in glial cells in the central nervous system: Expression and properties in neurodegeneration and injury. Front. Physiol. 2019;10:486. doi: 10.3389/fphys.2019.00486.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2019.00486</ArticleId><ArticleId IdType="pmc">PMC6499070</ArticleId><ArticleId IdType="pubmed">31105589</ArticleId></ArticleIdList></Reference><Reference><Citation>Fr&#xfc;hbeis C., Fr&#xf6;hlich D., Kr&#xe4;mer-Albers E.M. Emerging roles of exosomes in neuron-glia communication. Front. Physiol. 2012;3 APR doi: 10.3389/fphys.2012.00119.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2012.00119</ArticleId><ArticleId IdType="pmc">PMC3339323</ArticleId><ArticleId IdType="pubmed">22557979</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Den Bosch L., Tilkin P., Lemmens G., Robberecht W. Minocycline delays disease onset and mortality in a transgenic model of ALS. Neuroreport. 2002;13:1067&#x2013;1070. doi: 10.1097/00001756-200206120-00018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001756-200206120-00018</ArticleId><ArticleId IdType="pubmed">12060810</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller A.F., Gravel M., Kriz J. Treatment with minocycline after disease onset alters astrocyte reactivity and increases microgliosis in SOD1 mutant mice. Exp. Neurol. 2011;228:69&#x2013;79. doi: 10.1016/j.expneurol.2010.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2010.12.010</ArticleId><ArticleId IdType="pubmed">21168408</ArticleId></ArticleIdList></Reference><Reference><Citation>Geloso M.C., Corvino V., Marchese E., Serrano A., Michetti F., D&#x2019;Ambrosi N. The dual role of microglia in ALS: Mechanisms and therapeutic approaches. Front. Aging Neurosci. 2017;9:242. doi: 10.3389/fnagi.2017.00242.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00242</ArticleId><ArticleId IdType="pmc">PMC5524666</ArticleId><ArticleId IdType="pubmed">28790913</ArticleId></ArticleIdList></Reference><Reference><Citation>Henkel J.S., Beers D.R., Zhao W., Appel S.H. Microglia in ALS: The good, the bad, and the resting. J. Neuroimmune Pharmacol. 2009;4:389&#x2013;398. doi: 10.1007/s11481-009-9171-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-009-9171-5</ArticleId><ArticleId IdType="pubmed">19731042</ArticleId></ArticleIdList></Reference><Reference><Citation>C&#xf4;t&#xe9; F., Collard J.F., Julien J.P. Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: A mouse model of amyotrophic lateral sclerosis. Cell. 1993;73:35&#x2013;46. doi: 10.1016/0092-8674(93)90158-M.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(93)90158-M</ArticleId><ArticleId IdType="pubmed">8462101</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennel P.F., Finiels F., Revah F., Mallet J. Neuromuscular functicon impairment is not caused by motor neurone loss in FALS mice: An electromyographic study. Neuroreport. 1996;7:1427&#x2013;1431. doi: 10.1097/00001756-199605310-00021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001756-199605310-00021</ArticleId><ArticleId IdType="pubmed">8856691</ArticleId></ArticleIdList></Reference><Reference><Citation>Masrori P., Van Damme P. Amyotrophic lateral sclerosis: A clinical review. Eur. J. Neurol. 2020;27:1918&#x2013;1929. doi: 10.1111/ene.14393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14393</ArticleId><ArticleId IdType="pmc">PMC7540334</ArticleId><ArticleId IdType="pubmed">32526057</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinelli E.G., Riva N., Rancoita P.M.V., Schito P., Doretti A., Poletti B., Di Serio C., Silani V., Filippi M., Agosta F. Structural MRI outcomes and predictors of disease progression in amyotrophic lateral sclerosis. NeuroImage Clin. 2020;27 doi: 10.1016/j.nicl.2020.102315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2020.102315</ArticleId><ArticleId IdType="pmc">PMC7327879</ArticleId><ArticleId IdType="pubmed">32593977</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajagopalan V., Pioro E.P. Unbiased MRI analyses identify micropathologic differences between upper motor neuron-predominant ALS phenotypes. Front. Neurosci. 2019;13 doi: 10.3389/fnins.2019.00704.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00704</ArticleId><ArticleId IdType="pmc">PMC6639827</ArticleId><ArticleId IdType="pubmed">31354413</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzo G., Marliani A., Battaglia S., Albini Riccioli L., De Pasqua S., Vacchiano V., Infante R., Avoni P., Donadio V., Passaretti M., et al. Diagnostic and Prognostic Value of Conventional Brain MRI in the Clinical Work-Up of Patients with Amyotrophic Lateral Sclerosis. J. Clin. Med. 2020;9:2538. doi: 10.3390/jcm9082538.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9082538</ArticleId><ArticleId IdType="pmc">PMC7463468</ArticleId><ArticleId IdType="pubmed">32781557</ArticleId></ArticleIdList></Reference><Reference><Citation>Oeckl P., Weydt P., Thal D.R., Weishaupt J.H., Ludolph A.C., Otto M. Proteomics in cerebrospinal fluid and spinal cord suggests UCHL1, MAP2 and GPNMB as biomarkers and underpins importance of transcriptional pathways in amyotrophic lateral sclerosis. Acta Neuropathol. 2019;139:119&#x2013;134. doi: 10.1007/s00401-019-02093-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-02093-x</ArticleId><ArticleId IdType="pubmed">31701227</ArticleId></ArticleIdList></Reference><Reference><Citation>Raoul C., Est&#xe9;vez A.G., Nishimune H., Cleveland D.W., DeLapeyri&#xe8;re O., Henderson C.E., Haase G., Pettmann B. Motoneuron death triggered by a specific pathway downstream of Fas. potentiation by ALS-linked SOD1 mutations. Neuron. 2002;35:1067&#x2013;1083. doi: 10.1016/S0896-6273(02)00905-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(02)00905-4</ArticleId><ArticleId IdType="pubmed">12354397</ArticleId></ArticleIdList></Reference><Reference><Citation>Appel S.H., Zhao W., Beers D.R., Henkel J.S. The microglial-motoneuron dialogue in ALS. Acta Myol. 2011;30:4&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3185827</ArticleId><ArticleId IdType="pubmed">21842586</ArticleId></ArticleIdList></Reference><Reference><Citation>Clement A.M., Nguyen M.D., Roberts E.A., Garcia M.L., Boill&#xe9;e S., Rule M., McMahon A.P., Doucette W., Siwek D., Ferrante R.J., et al. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science. 2003;302:113&#x2013;117. doi: 10.1126/science.1086071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1086071</ArticleId><ArticleId IdType="pubmed">14526083</ArticleId></ArticleIdList></Reference><Reference><Citation>Endo F., Komine O., Fujimori-Tonou N., Katsuno M., Jin S., Watanabe S., Sobue G., Dezawa M., Wyss-Coray T., Yamanaka K. Astrocyte-Derived TGF-&#x3b2;1 Accelerates Disease Progression in ALS Mice by Interfering with the Neuroprotective Functions of Microglia and T Cells. Cell Rep. 2015 doi: 10.1016/j.celrep.2015.03.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2015.03.053</ArticleId><ArticleId IdType="pubmed">25892237</ArticleId></ArticleIdList></Reference><Reference><Citation>Costagli M., Donatelli G., Biagi L., Caldarazzo Ienco E., Siciliano G., Tosetti M., Cosottini M. Magnetic susceptibility in the deep layers of the primary motor cortex in Amyotrophic Lateral Sclerosis. NeuroImage Clin. 2016;12:965&#x2013;969. doi: 10.1016/j.nicl.2016.04.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2016.04.011</ArticleId><ArticleId IdType="pmc">PMC5153607</ArticleId><ArticleId IdType="pubmed">27995062</ArticleId></ArticleIdList></Reference><Reference><Citation>Jara J.H., Gen&#xe7; B., Stanford M.J., Pytel P., Roos R.P., Weintraub S., Mesulam M.M., Bigio E.H., Miller R.J., &#xd6;zdinler P.H. Evidence for an early innate immune response in the motor cortex of ALS. J. Neuroinflamm. 2017;14 doi: 10.1186/s12974-017-0896-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-017-0896-4</ArticleId><ArticleId IdType="pmc">PMC5485686</ArticleId><ArticleId IdType="pubmed">28651542</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W.W., Sidman R.L., Taksir T.V., Treleaven C.M., Fidler J.A., Cheng S.H., Dodge J.C., Shihabuddin L.S. Relationship between neuropathology and disease progression in the SOD1G93A ALS mouse. Exp. Neurol. 2011;227:287&#x2013;295. doi: 10.1016/j.expneurol.2010.11.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2010.11.019</ArticleId><ArticleId IdType="pubmed">21145892</ArticleId></ArticleIdList></Reference><Reference><Citation>Frakes A.E., Ferraiuolo L., Haidet-phillips A.M., Schmelzer L., Braun L., Miranda C.J., Ladner K.J., Bevan A.K., Kevin D., Godbout J.P., et al. Microglia induce motor neuron death via the classical NF-&#x3ba;B pathway in amyotrophic lateral sclerosis. Neuron. 2014;81:1009&#x2013;1023. doi: 10.1016/j.neuron.2014.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.01.013</ArticleId><ArticleId IdType="pmc">PMC3978641</ArticleId><ArticleId IdType="pubmed">24607225</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidet-phillips A.M., Hester M.E., Miranda C.J., Meyer K., Braun L., Frakes A., Song S., Likhite S., Matthew J., Foust K.D., et al. Astrocytes from Familial and Sporadic ALS Patients are Toxic to Motor Neurons. Nat Biotechnol. 2012;29:824&#x2013;828. doi: 10.1038/nbt.1957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1957</ArticleId><ArticleId IdType="pmc">PMC3170425</ArticleId><ArticleId IdType="pubmed">21832997</ArticleId></ArticleIdList></Reference><Reference><Citation>Swarup V., Phaneuf D., Dupr&#xe9; N., Petri S., Strong M., Kriz J., Julien J.-P. Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor &#x3ba;B&#x2013;mediated pathogenic pathways. J. Exp. Med. 2011;208:2429&#x2013;2447. doi: 10.1084/jem.20111313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20111313</ArticleId><ArticleId IdType="pmc">PMC3256969</ArticleId><ArticleId IdType="pubmed">22084410</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouali Alami N., Schurr C., Olde Heuvel F., Tang L., Li Q., Tasdogan A., Kimbara A., Nettekoven M., Ottaviani G., Raposo C., et al. NF-&#x3ba;B activation in astrocytes drives a stage-specific beneficial neuroimmunological response in ALS. EMBO J. 2018:e98697. doi: 10.15252/embj.201798697.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201798697</ArticleId><ArticleId IdType="pmc">PMC6092622</ArticleId><ArticleId IdType="pubmed">29875132</ArticleId></ArticleIdList></Reference><Reference><Citation>Crosio C., Valle C., Casciati A., Iaccarino C., Carr&#xec; M.T. Astroglial inhibition of NF-&#x3ba;b does not ameliorate disease onset and progression in a mouse model for amyotrophic lateral sclerosis (ALS) PLoS ONE. 2011;6 doi: 10.1371/journal.pone.0017187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0017187</ArticleId><ArticleId IdType="pmc">PMC3060799</ArticleId><ArticleId IdType="pubmed">21445241</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutierrez H., Hale V.A., Dolcet X., Davies A. NF- B signalling regulates the growth of neural processes in the developing PNS and CNS. Development. 2005;132:1713&#x2013;1726. doi: 10.1242/dev.01702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.01702</ArticleId><ArticleId IdType="pubmed">15743881</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaltschmidt B., Ndiaye D., Korte M., Pothion S., Arbibe L., Prullage M., Pfeiffer J., Lindecke A., Staiger V., Israel A., et al. NF- B Regulates Spatial Memory Formation and Synaptic Plasticity through Protein Kinase A/CREB Signaling. Mol. Cell. Biol. 2006;26:2936&#x2013;2946. doi: 10.1128/MCB.26.8.2936-2946.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.26.8.2936-2946.2006</ArticleId><ArticleId IdType="pmc">PMC1446931</ArticleId><ArticleId IdType="pubmed">16581769</ArticleId></ArticleIdList></Reference><Reference><Citation>Taoufik E., Tseveleki V., Chu S.Y., Tselios T., Karin M., Lassmann H., Szymkowski D.E., Probert L. Transmembrane tumour necrosis factor is neuroprotective and regulates experimental autoimmune encephalomyelitis via neuronal nuclear factor-&#x3ba;B. Brain. 2011;134:2722&#x2013;2735. doi: 10.1093/brain/awr203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr203</ArticleId><ArticleId IdType="pubmed">21908876</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardoso S.M., Oliveira C.R. Inhibition of NF-kB renders cells more vulnerable to apoptosis induced by amyloid beta peptides. Free Radic. Res. 2003;37:967&#x2013;973. doi: 10.1080/10715760310001595757.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10715760310001595757</ArticleId><ArticleId IdType="pubmed">28447528</ArticleId></ArticleIdList></Reference><Reference><Citation>Kettenmann H., Hanisch U.-K., Noda M., Verkhratsky A. Physiology of microglia. Physiol. Rev. 2011;91:461&#x2013;553. doi: 10.1152/physrev.00011.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00011.2010</ArticleId><ArticleId IdType="pubmed">21527731</ArticleId></ArticleIdList></Reference><Reference><Citation>Boillee S., Yamanaka K., Lobsiger C.S., Copeland N.G., Jenkins N.A., Kassiotis G., Kollias G., Cleveland D.W. Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia. Science. 2006;312:1389&#x2013;1392. doi: 10.1126/science.1123511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1123511</ArticleId><ArticleId IdType="pubmed">16741123</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers D.R., Henkel J.S., Xiao Q., Zhao W., Wang J., Yen A.A., Siklos L., McKercher S.R., Appel S.H. Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 2006;103:16021&#x2013;16026. doi: 10.1073/pnas.0607423103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0607423103</ArticleId><ArticleId IdType="pmc">PMC1613228</ArticleId><ArticleId IdType="pubmed">17043238</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu I.M., Morimoto E.T.A., Goodarzi H., Liao J.T., O&#x2019;Keeffe S., Phatnani H.P., Muratet M., Carroll M.C., Levy S., Tavazoie S., et al. A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model. Cell Rep. 2013;4:385&#x2013;401. doi: 10.1016/j.celrep.2013.06.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.06.018</ArticleId><ArticleId IdType="pmc">PMC4272581</ArticleId><ArticleId IdType="pubmed">23850290</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu D.-C., R&#xe9; D.B., Nagai M., Ischiropoulos H., Przedborski S. The inflammatory NADPH oxidase enzyme modulates motor neuron degeneration in amyotrophic lateral sclerosis mice. Proc. Natl. Acad. Sci. USA. 2006;103:12132&#x2013;12137. doi: 10.1073/pnas.0603670103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0603670103</ArticleId><ArticleId IdType="pmc">PMC1562547</ArticleId><ArticleId IdType="pubmed">16877542</ArticleId></ArticleIdList></Reference><Reference><Citation>Potolicchio I., Carven G.J., Xu X., Stipp C., Riese R.J., Stern L.J., Santambrogio L. Proteomic analysis of microglia-derived exosomes: Metabolic role of the aminopeptidase CD13 in neuropeptide catabolism. J. Immunol. 2005;175:2237&#x2013;2243. doi: 10.4049/jimmunol.175.4.2237.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.175.4.2237</ArticleId><ArticleId IdType="pubmed">16081791</ArticleId></ArticleIdList></Reference><Reference><Citation>Hooper C., Sainz-Fuertes R., Lynham S., Hye A., Killick R., Warley A., Bolondi C., Pocock J., Lovestone S. Wnt3a induces exosome secretion from primary cultured rat microglia. BMC Neurosci. 2012;13:144. doi: 10.1186/1471-2202-13-144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2202-13-144</ArticleId><ArticleId IdType="pmc">PMC3541220</ArticleId><ArticleId IdType="pubmed">23173708</ArticleId></ArticleIdList></Reference><Reference><Citation>Turola E., Furlan R., Bianco F., Matteoli M., Verderio C. Microglial microvesicle secretion and intercellular signaling. Front. Physiol. 2012;3:149. doi: 10.3389/fphys.2012.00149.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2012.00149</ArticleId><ArticleId IdType="pmc">PMC3357554</ArticleId><ArticleId IdType="pubmed">22661954</ArticleId></ArticleIdList></Reference><Reference><Citation>Parisi C., Arisi I., D&#x2019;Ambrosi N., Storti A.E., Brandi R., D&#x2019;Onofrio M., Volont&#xe9; C. Dysregulated microRNAs in amyotrophic lateral sclerosis microglia modulate genes linked to neuroinflammation. Cell Death Dis. 2013;4:e959. doi: 10.1038/cddis.2013.491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2013.491</ArticleId><ArticleId IdType="pmc">PMC3877562</ArticleId><ArticleId IdType="pubmed">24336079</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky O., Jedrychowski M.P., Cialic R., Krasemann S., Murugaiyan G., Fanek Z., Greco D.J., Wu P.M., Doykan C.E., Kiner O., et al. Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice. Ann. Neurol. 2015;77:75&#x2013;99. doi: 10.1002/ana.24304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24304</ArticleId><ArticleId IdType="pmc">PMC4432483</ArticleId><ArticleId IdType="pubmed">25381879</ArticleId></ArticleIdList></Reference><Reference><Citation>Koval E.D., Shaner C., Zhang P., du Maine X., Fischer K., Tay J., Chau B.N., Wu G.F., Miller T.M. Method for widespread microRNA-155 inhibition prolongs survival in ALS-model mice. Hum. Mol. Genet. 2013;22:4127&#x2013;4135. doi: 10.1093/hmg/ddt261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt261</ArticleId><ArticleId IdType="pmc">PMC3781640</ArticleId><ArticleId IdType="pubmed">23740943</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky O., Jedrychowski M.P., Moore C.S., Cialic R., Lanser A.J., Gabriely G., Koeglsperger T., Dake B., Wu P.M., Doykan C.E., et al. Identification of a unique TGF-&#x3b2;-dependent molecular and functional signature in microglia. Nat. Neurosci. 2014;17:131&#x2013;143. doi: 10.1038/nn.3599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3599</ArticleId><ArticleId IdType="pmc">PMC4066672</ArticleId><ArticleId IdType="pubmed">24316888</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammond T.R., Dufort C., Dissing-Olesen L., Giera S., Young A., Wysoker A., Walker A.J., Gergits F., Segel M., Nemesh J., et al. Single-Cell RNA Sequencing of Microglia throughout the Mouse Lifespan and in the Injured Brain Reveals Complex Cell-State Changes. Immunity. 2019;50:253&#x2013;271.e6. doi: 10.1016/j.immuni.2018.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2018.11.004</ArticleId><ArticleId IdType="pmc">PMC6655561</ArticleId><ArticleId IdType="pubmed">30471926</ArticleId></ArticleIdList></Reference><Reference><Citation>Sousa C., Golebiewska A., Poovathingal S.K., Kaoma T., Pires-Afonso Y., Martina S., Coowar D., Azuaje F., Skupin A., Balling R., et al. Single-cell transcriptomics reveals distinct inflammation-induced microglia signatures. EMBO Rep. 2018;19 doi: 10.15252/embr.201846171.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201846171</ArticleId><ArticleId IdType="pmc">PMC6216255</ArticleId><ArticleId IdType="pubmed">30206190</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett M.L., Bennett F.C., Liddelow S.A., Ajami B., Zamanian J.L., Fernhoff N.B., Mulinyawe S.B., Bohlen C.J., Adil A., Tucker A., et al. New tools for studying microglia in the mouse and human CNS. Proc. Natl. Acad. Sci. USA. 2016;113:E1738&#x2013;E1746. doi: 10.1073/pnas.1525528113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1525528113</ArticleId><ArticleId IdType="pmc">PMC4812770</ArticleId><ArticleId IdType="pubmed">26884166</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q., Cheng Z., Zhou L., Darmanis S., Neff N.F., Okamoto J., Gulati G., Bennett M.L., Sun L.O., Clarke L.E., et al. Developmental Heterogeneity of Microglia and Brain Myeloid Cells Revealed by Deep Single-Cell RNA Sequencing. Neuron. 2019;101:207&#x2013;223.e10. doi: 10.1016/j.neuron.2018.12.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.12.006</ArticleId><ArticleId IdType="pmc">PMC6336504</ArticleId><ArticleId IdType="pubmed">30606613</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldmann T., Wieghofer P., Jord&#xe3;o M.J.C., Prutek F., Hagemeyer N., Frenzel K., Amann L., Staszewski O., Kierdorf K., Krueger M., et al. Origin, fate and dynamics of macrophages at central nervous system interfaces. Nat. Immunol. 2016;17:797&#x2013;805. doi: 10.1038/ni.3423.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3423</ArticleId><ArticleId IdType="pmc">PMC4968048</ArticleId><ArticleId IdType="pubmed">27135602</ArticleId></ArticleIdList></Reference><Reference><Citation>Sala Frigerio C., Wolfs L., Fattorelli N., Thrupp N., Voytyuk I., Schmidt I., Mancuso R., Chen W.T., Woodbury M.E., Srivastava G., et al. The Major Risk Factors for Alzheimer&#x2019;s Disease: Age, Sex, and Genes Modulate the Microglia Response to A&#x3b2; Plaques. Cell Rep. 2019;27:1293&#x2013;1306.e6. doi: 10.1016/j.celrep.2019.03.099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.03.099</ArticleId><ArticleId IdType="pmc">PMC7340153</ArticleId><ArticleId IdType="pubmed">31018141</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasemann S., Madore C., Cialic R., Baufeld C., Calcagno N., El Fatimy R., Beckers L., O&#x2019;Loughlin E., Xu Y., Fanek Z., et al. The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases. Immunity. 2017;47:566&#x2013;581.e9. doi: 10.1016/j.immuni.2017.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2017.08.008</ArticleId><ArticleId IdType="pmc">PMC5719893</ArticleId><ArticleId IdType="pubmed">28930663</ArticleId></ArticleIdList></Reference><Reference><Citation>Holtman I.R., Raj D.D., Miller J.A., Schaafsma W., Yin Z., Brouwer N., Wes P.D., M&#xf6;ller T., Orre M., Kamphuis W., et al. Induction of a common microglia gene expression signature by aging and neurodegenerative conditions: A co-expression meta-analysis. Acta Neuropathol. Commun. 2015;3:31. doi: 10.1186/s40478-015-0203-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-015-0203-5</ArticleId><ArticleId IdType="pmc">PMC4489356</ArticleId><ArticleId IdType="pubmed">26001565</ArticleId></ArticleIdList></Reference><Reference><Citation>Keren-Shaul H., Spinrad A., Weiner A., Matcovitch-Natan O., Dvir-Szternfeld R., Ulland T.K., David E., Baruch K., Lara-Astaiso D., Toth B., et al. A Unique Microglia Type Associated with Restricting Development of Alzheimer&#x2019;s Disease. Cell. 2017;169:1276&#x2013;1290.e17. doi: 10.1016/j.cell.2017.05.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.05.018</ArticleId><ArticleId IdType="pubmed">28602351</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky O., Siddiqui S., Gabriely G., Lanser A.J., Dake B., Murugaiyan G., Doykan C.E., Wu P.M., Gali R.R., Iyer L.K., et al. Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. J. Clin. Investig. 2012;122:3063&#x2013;3087. doi: 10.1172/JCI62636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI62636</ArticleId><ArticleId IdType="pmc">PMC3428086</ArticleId><ArticleId IdType="pubmed">22863620</ArticleId></ArticleIdList></Reference><Reference><Citation>Maniatis S., &#xc4;ij&#xf6; T., Vickovic S., Braine C., Kang K., Mollbrink A., Fagegaltier D., Andrusivov&#xe1; &#x17d;., Saarenp&#xe4;&#xe4; S., Saiz-Castro G., et al. Spatiotemporal dynamics of molecular pathology in amyotrophic lateral sclerosis. Science. 2019;364:89&#x2013;93. doi: 10.1126/science.aav9776.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aav9776</ArticleId><ArticleId IdType="pubmed">30948552</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z., Jalabi W., Shpargel K.B., Farabaugh K.T., Dutta R., Yin X., Kiddds G.J., Bergmann C.C., Stohlman S.A., Trapp B.D. Lipopolysaccharide-induced microglial activation and neuroprotection against experimental brain injury is independent of hematogenous TLR4. J. Neurosci. 2012;32:11706&#x2013;11715. doi: 10.1523/JNEUROSCI.0730-12.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0730-12.2012</ArticleId><ArticleId IdType="pmc">PMC4461442</ArticleId><ArticleId IdType="pubmed">22915113</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouchard C., Pag&#xe9; J., B&#xe9;dard A., Tremblay P., Valli&#xe8;res L. G protein-coupled receptor 84, a microglia-associated protein expressed in neuroinflammatory conditions. Glia. 2007;55:790&#x2013;800. doi: 10.1002/glia.20506.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.20506</ArticleId><ArticleId IdType="pubmed">17390309</ArticleId></ArticleIdList></Reference><Reference><Citation>Recio C., Lucy D., Purvis G.S.D., Iveson P., Zeboudj L., Iqbal A.J., Lin D., O&#x2019;Callaghan C., Davison L., Griesbach E., et al. Activation of the immune-metabolic receptor GPR84 enhances inflammation and phagocytosis in macrophages. Front. Immunol. 2018;9 doi: 10.3389/fimmu.2018.01419.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01419</ArticleId><ArticleId IdType="pmc">PMC6019444</ArticleId><ArticleId IdType="pubmed">29973940</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas A., Kenna K., Renton A.E., Ticozzi N., Faghri F., Chia R., Dominov J.A., Kenna B.J., Nalls M.A., Keagle P., et al. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene. Neuron. 2018;97:1268&#x2013;1283.e6. doi: 10.1016/j.neuron.2018.02.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.02.027</ArticleId><ArticleId IdType="pmc">PMC5867896</ArticleId><ArticleId IdType="pubmed">29566793</ArticleId></ArticleIdList></Reference><Reference><Citation>Saunders A., Macosko E.Z., Wysoker A., Goldman M., Krienen F.M., de Rivera H., Bien E., Baum M., Bortolin L., Wang S., et al. Molecular Diversity and Specializations among the Cells of the Adult Mouse Brain. Cell. 2018;174:1015&#x2013;1030.e16. doi: 10.1016/j.cell.2018.07.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.07.028</ArticleId><ArticleId IdType="pmc">PMC6447408</ArticleId><ArticleId IdType="pubmed">30096299</ArticleId></ArticleIdList></Reference><Reference><Citation>Dols-Icardo O., Montal V., Sirisi S., L&#xf3;pez-Pernas G., Cervera-Carles L., Querol-Vilaseca M., Mu&#xf1;oz L., Belbin O., Alcolea D., Molina-Porcel L., et al. Motor cortex transcriptome reveals microglial key events in amyotrophic lateral sclerosis. Neurol. Neuroimmunol. Neuroinflamm. 2020;7 doi: 10.1212/NXI.0000000000000829.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000829</ArticleId><ArticleId IdType="pmc">PMC7371375</ArticleId><ArticleId IdType="pubmed">32669313</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Cella M., Mallinson K., Ulrich J.D., Young K.L., Robinette M.L., Gilfillan S., Krishnan G.M., Sudhakar S., Zinselmeyer B.H., et al. TREM2 lipid sensing sustains the microglial response in an Alzheimer&#x2019;s disease model. Cell. 2015;160:1061&#x2013;1071. doi: 10.1016/j.cell.2015.01.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.01.049</ArticleId><ArticleId IdType="pmc">PMC4477963</ArticleId><ArticleId IdType="pubmed">25728668</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou S.L., Tan C.C., Hou X.H., Cao X.P., Tan L., Yu J.T. TREM2 Variants and Neurodegenerative Diseases: A Systematic Review and Meta-Analysis. J. Alzheimer&#x2019;s Dis. 2019;68:1171&#x2013;1184. doi: 10.3233/JAD-181038.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-181038</ArticleId><ArticleId IdType="pubmed">30883352</ArticleId></ArticleIdList></Reference><Reference><Citation>Svahn A.J., Don E.K., Badrock A.P., Cole N.J., Graeber M.B., Yerbury J.J., Chung R., Morsch M. Nucleo-cytoplasmic transport of TDP-43 studied in real time: Impaired microglia function leads to axonal spreading of TDP-43 in degenerating motor neurons. Acta Neuropathol. 2018;136:445&#x2013;459. doi: 10.1007/s00401-018-1875-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1875-2</ArticleId><ArticleId IdType="pmc">PMC6096729</ArticleId><ArticleId IdType="pubmed">29943193</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiller K.J., Restrepo C.R., Khan T., Dominique M.A., Fang T.C., Canter R.G., Roberts C.J., Miller K.R., Ransohoff R.M., Trojanowski J.Q., et al. Microglia-mediated recovery from ALS-relevant motor neuron degeneration in a mouse model of TDP-43 proteinopathy. Nat. Neurosci. 2018;21:329&#x2013;340. doi: 10.1038/s41593-018-0083-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0083-7</ArticleId><ArticleId IdType="pmc">PMC5857237</ArticleId><ArticleId IdType="pubmed">29463850</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xf6;ttcher C., Schlickeiser S., Sneeboer M.A.M., Kunkel D., Knop A., Paza E., Fidzinski P., Kraus L., Snijders G.J.L., Kahn R.S., et al. Human microglia regional heterogeneity and phenotypes determined by multiplexed single-cell mass cytometry. Nat. Neurosci. 2019;22:78&#x2013;90. doi: 10.1038/s41593-018-0290-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0290-2</ArticleId><ArticleId IdType="pubmed">30559476</ArticleId></ArticleIdList></Reference><Reference><Citation>St&#xe5;hl P.L., Salm&#xe9;n F., Vickovic S., Lundmark A., Navarro J.F., Magnusson J., Giacomello S., Asp M., Westholm J.O., Huss M., et al. Visualization and analysis of gene expression in tissue sections by spatial transcriptomics. Science. 2016;353:78&#x2013;82. doi: 10.1126/science.aaf2403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf2403</ArticleId><ArticleId IdType="pubmed">27365449</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriques S.G., Stickels R.R., Goeva A., Martin C.A., Murray E., Vanderburg C.R., Welch J., Chen L.M., Chen F., Macosko E.Z. Slide-seq: A scalable technology for measuring genome-wide expression at high spatial resolution. Science. 2019;363:1463&#x2013;1467. doi: 10.1126/science.aaw1219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaw1219</ArticleId><ArticleId IdType="pmc">PMC6927209</ArticleId><ArticleId IdType="pubmed">30923225</ArticleId></ArticleIdList></Reference><Reference><Citation>Stickels R., Murray E., Kumar P., Li J., Marshall J., Di Bella D., Arlotta P., Macosko E., Chen F. Sensitive spatial genome wide expression profiling at cellular resolution. bioRxiv. 2020 doi: 10.1101/2020.03.12.989806.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.03.12.989806</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajami B., Samusik N., Wieghofer P., Ho P.P., Crotti A., Bjornson Z., Prinz M., Fantl W.J., Nolan G.P., Steinman L. Single-cell mass cytometry reveals distinct populations of brain myeloid cells in mouse neuroinflammation and neurodegeneration models. Nat. Neurosci. 2018 doi: 10.1038/s41593-018-0100-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0100-x</ArticleId><ArticleId IdType="pubmed">29507414</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelhardt J.I., Appel S.H. IgG reactivity in the spinal cord and motor cortex in amyotrophic lateral sclerosis. Arch. Neurol. 1990;47:1210&#x2013;1216. doi: 10.1001/archneur.1990.00530110068019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1990.00530110068019</ArticleId><ArticleId IdType="pubmed">2122877</ArticleId></ArticleIdList></Reference><Reference><Citation>Banati R.B., Gehrmann J., Kellner M., Holsboer F. Antibodies against microglia/brain macrophages in the cerebrospinal fluid of a patient with acute amyotrophic lateral sclerosis and presenile dementia. Clin. Neuropathol. 1995;14:197&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pubmed">8521621</ArticleId></ArticleIdList></Reference><Reference><Citation>Henkel J.S., Engelhardt J.I., Sikl&#xf3;s L., Simpson E.P., Kim S.H., Pan T., Goodman J.C., Siddique T., Beers D.R., Appel S.H. Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann. Neurol. 2004;55:221&#x2013;235. doi: 10.1002/ana.10805.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.10805</ArticleId><ArticleId IdType="pubmed">14755726</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner M.R., Cagnin A., Turkheimer F.E., Miller C.C.J., Shaw C.E., Brooks D.J., Leigh P.N., Banati R.B. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: An [11C](R)-PK11195 positron emission tomography study. Neurobiol. Dis. 2004;15:601&#x2013;609. doi: 10.1016/j.nbd.2003.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2003.12.012</ArticleId><ArticleId IdType="pubmed">15056468</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan J., Lindemann P., Feuilloley M.G.J., Papadopoulos V. Structural and functional evolution of the translocator protein (18 kDa) Curr. Mol. Med. 2012;12:369&#x2013;386. doi: 10.2174/1566524011207040369.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1566524011207040369</ArticleId><ArticleId IdType="pubmed">22364126</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatliff J., Campanella M. TSPO: Kaleidoscopic 18-kDa amid biochemical pharmacology, control and targeting of mitochondria. Biochem. J. 2016;473:107&#x2013;121. doi: 10.1042/BJ20150899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20150899</ArticleId><ArticleId IdType="pubmed">26733718</ArticleId></ArticleIdList></Reference><Reference><Citation>Veenman L., Gavish M. The role of 18 kDa mitochondrial translocator protein (TSPO) in programmed cell death, and effects of steroids on TSPO expression. Curr. Mol. Med. 2012;12:398&#x2013;412.</Citation><ArticleIdList><ArticleId IdType="pubmed">22348610</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardwick M., Fertikh D., Culty M., Li H., Vidic B., Papadopoulos V. Peripheral-type benzodiazepine receptor (PBR) in human breast cancer: Correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBR-mediated cell proliferation and nuclear transport of cholesterol. Cancer Res. 1999;59:831&#x2013;842.</Citation><ArticleIdList><ArticleId IdType="pubmed">10029072</ArticleId></ArticleIdList></Reference><Reference><Citation>Olson J.M., Ciliax B.J., Mancini W.R., Young A.B. Presence of peripheral-type benzodiazepine binding sites on human erythrocyte membranes. Eur. J. Pharmacol. 1988;152:47&#x2013;53. doi: 10.1016/0014-2999(88)90834-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0014-2999(88)90834-5</ArticleId><ArticleId IdType="pubmed">2850202</ArticleId></ArticleIdList></Reference><Reference><Citation>Prinz W.A. Bridging the gap: Membrane contact sites in signaling, metabolism, and organelle dynamics. J. Cell Biol. 2014;205:759&#x2013;769. doi: 10.1083/jcb.201401126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201401126</ArticleId><ArticleId IdType="pmc">PMC4068136</ArticleId><ArticleId IdType="pubmed">24958771</ArticleId></ArticleIdList></Reference><Reference><Citation>Krols M., van Isterdael G., Asselbergh B., Kremer A., Lippens S., Timmerman V., Janssens S. Mitochondria-associated membranes as hubs for neurodegeneration. Acta Neuropathol. 2016;131:505&#x2013;523. doi: 10.1007/s00401-015-1528-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1528-7</ArticleId><ArticleId IdType="pmc">PMC4789254</ArticleId><ArticleId IdType="pubmed">26744348</ArticleId></ArticleIdList></Reference><Reference><Citation>Boutin H., Murray K., Pradillo J., Maroy R., Smigova A., Gerhard A., Jones P.A., Trigg W. 18F-GE-180: A novel TSPO radiotracer compared to 11C-R-PK11195 in a preclinical model of stroke. Eur. J. Nucl. Med. Mol. Imaging. 2014;42:503&#x2013;511. doi: 10.1007/s00259-014-2939-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-014-2939-8</ArticleId><ArticleId IdType="pubmed">25351507</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B., Le K.X., Park M., Wang S., Belanger A.P., Dubey X., Frost J.L., Holton P., Reiser V., Jones X.P.A., et al. In Vivo Detection of Age- and Disease-Related Increases in Neuroinflammation by 18 F-GE180 TSPO MicroPET Imaging in Wild-Type and Alzheimer&#x2019;s Transgenic Mice. J. Neurosci. 2015;35:15716&#x2013;15730. doi: 10.1523/JNEUROSCI.0996-15.2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0996-15.2015</ArticleId><ArticleId IdType="pmc">PMC6705465</ArticleId><ArticleId IdType="pubmed">26609163</ArticleId></ArticleIdList></Reference><Reference><Citation>Gargiulo S., Anzilotti S., Coda A.R.D., Gramanzini M., Greco A., Panico M., Vinciguerra A., Zannetti A., Vicidomini C., Doll&#xe9; F., et al. Imaging of brain TSPO expression in a mouse model of amyotrophic lateral sclerosis with 18F-DPA-714 and micro-PET/CT. Eur. J. Nucl. Med. Mol. Imaging. 2016;43:1348&#x2013;1359. doi: 10.1007/s00259-016-3311-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-016-3311-y</ArticleId><ArticleId IdType="pubmed">26816193</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcia P., Tauber C., Vercoullie J., Arlicot N., Prunier C., Praline J., Nicolas G., Venel Y., Hommet C., Baulieu J.-L., et al. Molecular imaging of microglial activation in amyotrophic lateral sclerosis. PLoS ONE. 2012;7:e52941. doi: 10.1371/journal.pone.0052941.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0052941</ArticleId><ArticleId IdType="pmc">PMC3534121</ArticleId><ArticleId IdType="pubmed">23300829</ArticleId></ArticleIdList></Reference><Reference><Citation>Visigalli I., Moresco R.M., Belloli S., Politi L.S., Gritti A., Ungaro D., Matarrese M., Turolla E., Falini A., Scotti G., et al. Monitoring disease evolution and treatment response in lysosomal disorders by the peripheral benzodiazepine receptor ligand PK11195. Neurobiol. Dis. 2009;34:51&#x2013;62. doi: 10.1016/j.nbd.2008.12.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2008.12.019</ArticleId><ArticleId IdType="pubmed">19320046</ArticleId></ArticleIdList></Reference><Reference><Citation>Salsano E., Marotta G., Manfredi V., Giovagnoli A.R., Farina L., Savoiardo M., Pareyson D., Benti R., Uziel G. Brain fluorodeoxyglucose PET in adrenoleukodystrophy. Neurology. 2014;83:981&#x2013;989. doi: 10.1212/WNL.0000000000000770.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000770</ArticleId><ArticleId IdType="pubmed">25098542</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavisse S., Guillermier M., H&#xe9;rard A.-S., Petit F., Delahaye M., Van Camp N., Ben Haim L., Lebon V., Remy P., Doll&#xe9; F., et al. Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging. J. Neurosci. 2012;32:10809&#x2013;10818. doi: 10.1523/JNEUROSCI.1487-12.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1487-12.2012</ArticleId><ArticleId IdType="pmc">PMC6621018</ArticleId><ArticleId IdType="pubmed">22875916</ArticleId></ArticleIdList></Reference><Reference><Citation>Venneti S., Wang G., Nguyen J., Wiley C.A. The positron emission tomography ligand DAA1106 binds with high affinity to activated microglia in human neurological disorders. J. Neuropathol. Exp. Neurol. 2008;67:1001&#x2013;1010. doi: 10.1097/NEN.0b013e318188b204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e318188b204</ArticleId><ArticleId IdType="pmc">PMC2669281</ArticleId><ArticleId IdType="pubmed">18800007</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M.-K., Guilarte T.R. Translocator protein 18 kDa (TSPO): Molecular sensor of brain injury and repair. Pharmacol. Ther. 2008;118:1&#x2013;17. doi: 10.1016/j.pharmthera.2007.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2007.12.004</ArticleId><ArticleId IdType="pmc">PMC2453598</ArticleId><ArticleId IdType="pubmed">18374421</ArticleId></ArticleIdList></Reference><Reference><Citation>Venneti S., Lopresti B.J., Wang G., Hamilton R.L., Mathis C.A., Klunk W.E., Apte U.M., Wiley C.A. PK11195 labels activated microglia in Alzheimer&#x2019;s disease and in vivo in a mouse model using PET. Neurobiol. Aging. 2009;30:1217&#x2013;1226. doi: 10.1016/j.neurobiolaging.2007.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2007.11.005</ArticleId><ArticleId IdType="pmc">PMC2745919</ArticleId><ArticleId IdType="pubmed">18178291</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Weehaeghe D., Babu S., De Vocht J., Zurcher N.R., Chew S., Tseng C.-E.J., Loggia M., Koole M., Rezaei A., Schramm G., et al. Moving towards multicenter therapeutic trials in ALS: Feasibility of data pooling using different TSPO positron emission tomography (PET) radioligands. J. Nucl. Med. 2020 doi: 10.2967/jnumed.119.241059.</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.119.241059</ArticleId><ArticleId IdType="pubmed">32169920</ArticleId></ArticleIdList></Reference><Reference><Citation>Petit-Tabou&#xe9; M.C., Baron J.C., Barr&#xe9; L., Trav&#xe8;re J.M., Speckel D., Camsonne R., MacKenzie E.T. Brain kinetics and specific binding of [11C]PK 11195 to &#x3c9;3 sites in baboons: Positron emission tomography study. Eur. J. Pharmacol. 1991;200:347&#x2013;351. doi: 10.1016/0014-2999(91)90594-G.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0014-2999(91)90594-G</ArticleId><ArticleId IdType="pubmed">1782994</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah F., Hume S.P., Pike V.W., Ashworth S., McDermott J. Synthesis of the enantiomers of [N-methyl-11C]PK 11195 and comparison of their behaviours as radioligands for PK binding sites in rats. Nucl. Med. Biol. 1994;21:573&#x2013;581. doi: 10.1016/0969-8051(94)90022-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0969-8051(94)90022-1</ArticleId><ArticleId IdType="pubmed">9234314</ArticleId></ArticleIdList></Reference><Reference><Citation>James M.L., Fulton R.R., Vercoullie J., Henderson D.J., Garreau L., Chalon S., Dolle F., Selleri S., Guilloteau D., Kassiou M. DPA-714, a new translocator protein-specific ligand: Synthesis, radiofluorination, and pharmacologic characterization. J. Nucl. Med. 2008;49:814&#x2013;822. doi: 10.2967/jnumed.107.046151.</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.107.046151</ArticleId><ArticleId IdType="pubmed">18413395</ArticleId></ArticleIdList></Reference><Reference><Citation>Sridharan S., Lepelletier F.-X., Trigg W., Banister S., Reekie T., Kassiou M., Gerhard A., Hinz R., Boutin H. Comparative Evaluation of Three TSPO PET Radiotracers in a LPS-Induced Model of Mild Neuroinflammation in Rats. Mol. Imaging Biol. 2017;19:77&#x2013;89. doi: 10.1007/s11307-016-0984-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11307-016-0984-3</ArticleId><ArticleId IdType="pmc">PMC5209405</ArticleId><ArticleId IdType="pubmed">27481358</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni S., Alshikho M.J., Z&#xfc;rcher N.R., Cernasov P., Babu S., Loggia M.L., Chan J., Chonde D.B., Garcia D.I., Catana C., et al. Imaging of glia activation in people with primary lateral sclerosis. NeuroImage Clin. 2018;17:347&#x2013;353. doi: 10.1016/j.nicl.2017.10.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2017.10.024</ArticleId><ArticleId IdType="pmc">PMC5681341</ArticleId><ArticleId IdType="pubmed">29159046</ArticleId></ArticleIdList></Reference><Reference><Citation>Z&#xfc;rcher N.R., Loggia M.L., Lawson R., Chonde D.B., Izquierdo-Garcia D., Yasek J.E., Akeju O., Catana C., Rosen B.R., Cudkowicz M.E., et al. Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: Assessed with [11C]-PBR28. NeuroImage Clin. 2015;7:409&#x2013;414. doi: 10.1016/j.nicl.2015.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2015.01.009</ArticleId><ArticleId IdType="pmc">PMC4310932</ArticleId><ArticleId IdType="pubmed">25685708</ArticleId></ArticleIdList></Reference><Reference><Citation>Owen D.R., Yeo A.J., Gunn R.N., Song K., Wadsworth G., Lewis A., Rhodes C., Pulford D.J., Bennacef I., Parker C.A., et al. An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28. J. Cereb. Blood Flow Metab. 2012;32:1&#x2013;5. doi: 10.1038/jcbfm.2011.147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jcbfm.2011.147</ArticleId><ArticleId IdType="pmc">PMC3323305</ArticleId><ArticleId IdType="pubmed">22008728</ArticleId></ArticleIdList></Reference><Reference><Citation>Tondo G., Iaccarino L., Cerami C., Vanoli G.E., Presotto L., Masiello V., Coliva A., Salvi F., Bartolomei I., Mosca L., et al. C-PK11195 PET &#x2013; based molecular study of microglia activation in SOD1 amyotrophic lateral sclerosis. Ann. Clin. Transl. Neurol. 2020 doi: 10.1002/acn3.51112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51112</ArticleId><ArticleId IdType="pmc">PMC7480909</ArticleId><ArticleId IdType="pubmed">32762033</ArticleId></ArticleIdList></Reference><Reference><Citation>Yiangou Y., Facer P., Durrenberger P., Chessell I.P., Naylor A., Bountra C., Banati R.R., Anand P. COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord. BMC Neurol. 2006;6 doi: 10.1186/1471-2377-6-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-6-12</ArticleId><ArticleId IdType="pmc">PMC1413551</ArticleId><ArticleId IdType="pubmed">16512913</ArticleId></ArticleIdList></Reference><Reference><Citation>Moldovan R.P., Teodoro R., Gao Y., Deuther-Conrad W., Kranz M., Wang Y., Kuwabara H., Nakano M., Valentine H., Fischer S., et al. Development of a High-Affinity PET Radioligand for Imaging Cannabinoid Subtype 2 Receptor. J. Med. Chem. 2016;59:7840&#x2013;7855. doi: 10.1021/acs.jmedchem.6b00554.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jmedchem.6b00554</ArticleId><ArticleId IdType="pubmed">27500461</ArticleId></ArticleIdList></Reference><Reference><Citation>Slavik R., Grether U., M&#xfc;ller Herde A., Gobbi L., Fingerle J., Ullmer C., Kr&#xe4;mer S.D., Schibli R., Mu L., Ametamey S.M. Discovery of a high affinity and selective pyridine analog as a potential positron emission tomography imaging agent for cannabinoid type 2 receptor. J. Med. Chem. 2015;58:4266&#x2013;4277. doi: 10.1021/acs.jmedchem.5b00283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jmedchem.5b00283</ArticleId><ArticleId IdType="pubmed">25950914</ArticleId></ArticleIdList></Reference><Reference><Citation>Espejo-Porras F., Piscitelli F., Verde R., Ramos J.A., Di Marzo V., de Lago E., Fern&#xe1;ndez-Ruiz J. Changes in the endocannabinoid signaling system in CNS structures of TDP-43 transgenic mice: Relevance for a neuroprotective therapy in TDP-43-related disorders. J. Neuroimmune Pharmacol. 2015;10:233&#x2013;244. doi: 10.1007/s11481-015-9602-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-015-9602-4</ArticleId><ArticleId IdType="pubmed">25819934</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoemaker J.L., Seely K.A., Reed R.L., Crow J.P., Prather P.L. The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset. J. Neurochem. 2007;101:87&#x2013;98. doi: 10.1111/j.1471-4159.2006.04346.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2006.04346.x</ArticleId><ArticleId IdType="pmc">PMC2819701</ArticleId><ArticleId IdType="pubmed">17241118</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Kim J. CB2 Cannabinoid Receptor Knockout in Mice Impairs Contextual Long-Term Memory and Enhances Spatial Working Memory. Neural Plast. 2016;2016 doi: 10.1155/2016/9817089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/9817089</ArticleId><ArticleId IdType="pmc">PMC4706977</ArticleId><ArticleId IdType="pubmed">26819779</ArticleId></ArticleIdList></Reference><Reference><Citation>Palazuelos J., Ortega Z., D&#xed;az-Alonso J., Guzm&#xe1;n M., Galve-Roperh I. CB 2 cannabinoid receptors promote neural progenitor cell proliferation via mTORC1 signaling. J. Biol. Chem. 2012;287:1198&#x2013;1209. doi: 10.1074/jbc.M111.291294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.291294</ArticleId><ArticleId IdType="pmc">PMC3256884</ArticleId><ArticleId IdType="pubmed">22102284</ArticleId></ArticleIdList></Reference><Reference><Citation>Duff G., Argaw A., Cecyre B., Cherif H., Tea N., Zabouri N., Casanova C., Ptito M., Bouchard J.-F. Cannabinoid Receptor CB2 Modulates Axon Guidance. PLoS ONE. 2013;8:e70849. doi: 10.1371/journal.pone.0070849.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0070849</ArticleId><ArticleId IdType="pmc">PMC3739758</ArticleId><ArticleId IdType="pubmed">23951024</ArticleId></ArticleIdList></Reference><Reference><Citation>Castillo P.E., Younts T.J., Ch&#xe1;vez A.E., Hashimotodani Y. Endocannabinoid Signaling and Synaptic Function. Neuron. 2012;76:70&#x2013;81. doi: 10.1016/j.neuron.2012.09.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2012.09.020</ArticleId><ArticleId IdType="pmc">PMC3517813</ArticleId><ArticleId IdType="pubmed">23040807</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J., Li Y. Chronic activation of CB2 cannabinoid receptors in the hippocampus increases excitatory synaptic transmission. J. Physiol. 2015;593:871&#x2013;886. doi: 10.1113/jphysiol.2014.286633.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2014.286633</ArticleId><ArticleId IdType="pmc">PMC4398527</ArticleId><ArticleId IdType="pubmed">25504573</ArticleId></ArticleIdList></Reference><Reference><Citation>Calignano A., La Rana G., Giuffrida A., Piomelli D. Control of pain initiation by endogenous cannabinoids. Nature. 1998;394:277&#x2013;281. doi: 10.1038/28393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/28393</ArticleId><ArticleId IdType="pubmed">9685157</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiteside G., Lee G., Valenzano K. The Role of the Cannabinoid CB2 Receptor in Pain Transmission and Therapeutic Potential of Small Molecule CB2 Receptor Agonists. Curr. Med. Chem. 2007;14:917&#x2013;936. doi: 10.2174/092986707780363023.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/092986707780363023</ArticleId><ArticleId IdType="pubmed">17430144</ArticleId></ArticleIdList></Reference><Reference><Citation>Walter L., Franklin A., Witting A., Wade C., Xie Y., Kunos G., Mackie K., Stella N. Nonpsychotropic Cannabinoid Receptors Regulate Microglial Cell Migration. Microglial Cell Migration. 2003;23:1398&#x2013;1405. doi: 10.1523/JNEUROSCI.23-04-01398.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.23-04-01398.2003</ArticleId><ArticleId IdType="pmc">PMC6742252</ArticleId><ArticleId IdType="pubmed">12598628</ArticleId></ArticleIdList></Reference><Reference><Citation>Guida F., Luongo L., Boccella S., Giordano M.E., Romano R., Bellini G., Manzo I., Furiano A., Rizzo A., Imperatore R., et al. Palmitoylethanolamide induces microglia changes associated with increased migration and phagocytic activity: Involvement of the CB2 receptor. Sci. Rep. 2017;7 doi: 10.1038/s41598-017-00342-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-00342-1</ArticleId><ArticleId IdType="pmc">PMC5428303</ArticleId><ArticleId IdType="pubmed">28336953</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma L., Jia J., Liu X., Bai F., Wang Q., Xiong L. Activation of murine microglial N9 cells is attenuated through cannabinoid receptor CB2 signaling. Biochem. Biophys. Res. Commun. 2015;458:92&#x2013;97. doi: 10.1016/j.bbrc.2015.01.073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2015.01.073</ArticleId><ArticleId IdType="pubmed">25637536</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka M., Sackett S., Zhang Y. Endocannabinoid Modulation of Microglial Phenotypes in Neuropathology. Front. Neurol. 2020;11 doi: 10.3389/fneur.2020.00087.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00087</ArticleId><ArticleId IdType="pmc">PMC7033501</ArticleId><ArticleId IdType="pubmed">32117037</ArticleId></ArticleIdList></Reference><Reference><Citation>Malek N., Popiolek-Barczyk K., Mika J., Przewlocka B., Starowicz K. Anandamide, acting via CB2 receptors, alleviates LPS-induced neuroinflammation in rat primary microglial cultures. Neural Plast. 2015;2015 doi: 10.1155/2015/130639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/130639</ArticleId><ArticleId IdType="pmc">PMC4452105</ArticleId><ArticleId IdType="pubmed">26090232</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoppi S., Madrigal J.L., Caso J.R., Garc&#xed;a-Guti&#xe9;rrez M.S., Manzanares J., Leza J.C., Garc&#xed;a-Bueno B. Regulatory role of the cannabinoid CB2 receptor in stress-induced neuroinflammation in mice. Br. J. Pharmacol. 2014;171:2814&#x2013;2826. doi: 10.1111/bph.12607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.12607</ArticleId><ArticleId IdType="pmc">PMC4243857</ArticleId><ArticleId IdType="pubmed">24467609</ArticleId></ArticleIdList></Reference><Reference><Citation>Apolloni S., Amadio S., Parisi C., Matteucci A., Potenza R.L., Armida M., Popoli P., D&#x2019;Ambrosi N., Volont&#xe9; C. Spinal cord pathology is ameliorated by P2X7 antagonism in a SOD1-mutant mouse model of amyotrophic lateral sclerosis. Dis. Model. Mech. 2014;7:1101&#x2013;1109. doi: 10.1242/dmm.017038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.017038</ArticleId><ArticleId IdType="pmc">PMC4142730</ArticleId><ArticleId IdType="pubmed">25038061</ArticleId></ArticleIdList></Reference><Reference><Citation>Horti A.G., Gao Y., Ravert H.T., Finley P., Valentine H., Wong D.F., Endres C.J., Savonenko A.V., Dannals R.F. Synthesis and biodistribution of [11C]A-836339, a new potential radioligand for PET imaging of cannabinoid type 2 receptors (CB2) Bioorganic Med. Chem. 2010;18:5202&#x2013;5207. doi: 10.1016/j.bmc.2010.05.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmc.2010.05.058</ArticleId><ArticleId IdType="pmc">PMC2903661</ArticleId><ArticleId IdType="pubmed">20554448</ArticleId></ArticleIdList></Reference><Reference><Citation>Savonenko A.V., Melnikova T., Wang Y., Ravert H., Gao Y., Koppel J., Lee D., Pletnikova O., Cho E., Sayyida N., et al. Cannabinoid CB2 Receptors in a Mouse Model of A&#x3b2; Amyloidosis: Immunohistochemical Analysis and Suitability as a PET Biomarker of Neuroinflammation. PLoS ONE. 2015;10:e0129618. doi: 10.1371/journal.pone.0129618.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0129618</ArticleId><ArticleId IdType="pmc">PMC4472959</ArticleId><ArticleId IdType="pubmed">26086915</ArticleId></ArticleIdList></Reference><Reference><Citation>Evens N., Vandeputte C., Coolen C., Janssen P., Sciot R., Baekelandt V., Verbruggen A.M., Debyser Z., Van Laere K., Bormans G.M. Preclinical evaluation of [ 11C]NE40, a type 2 cannabinoid receptor PET tracer. Nucl. Med. Biol. 2012;39:389&#x2013;399. doi: 10.1016/j.nucmedbio.2011.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nucmedbio.2011.09.005</ArticleId><ArticleId IdType="pubmed">22154685</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad R., Koole M., Evens N., Serdons K., Verbruggen A., Bormans G., Van Laere K. Whole-body biodistribution and radiation dosimetry of the cannabinoid type 2 receptor ligand [11C]-NE40 in healthy subjects. Mol. Imaging Biol. 2013;15:384&#x2013;390. doi: 10.1007/s11307-013-0626-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11307-013-0626-y</ArticleId><ArticleId IdType="pubmed">23508466</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosoya T., Fukumoto D., Kakiuchi T., Nishiyama S., Yamamoto S., Ohba H., Tsukada H., Ueki T., Sato K., Ouchi Y. In vivo TSPO and cannabinoid receptor type 2 availability early in post-stroke neuroinflammation in rats: A positron emission tomography study. J. Neuroinflamm. 2017;14:69. doi: 10.1186/s12974-017-0851-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-017-0851-4</ArticleId><ArticleId IdType="pmc">PMC5372312</ArticleId><ArticleId IdType="pubmed">28356120</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamagishi S., Iga Y., Nakamura M., Takizawa C., Fukumoto D., Kakiuchi T., Nishiyama S., Ohba H., Tsukada H., Sato K., et al. Upregulation of cannabinoid receptor type 2, but not TSPO, in senescence-accelerated neuroinflammation in mice: A positron emission tomography study. J. Neuroinflamm. 2019;16 doi: 10.1186/s12974-019-1604-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-019-1604-3</ArticleId><ArticleId IdType="pmc">PMC6842455</ArticleId><ArticleId IdType="pubmed">31707986</ArticleId></ArticleIdList></Reference><Reference><Citation>Slavik R., Bieri D., Ermak S.&#x10c;., M&#xfc;ller A., Kr&#xe4;mer S.D., Weber M., Schibli R., Ametamey S.M., Mu L. Development and evaluation of novel pet tracers for imaging cannabinoid receptor type 2 in brain. CHIMIA Int. J. Chem. 2014;68:208&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pubmed">24983598</ArticleId></ArticleIdList></Reference><Reference><Citation>Haider A., Kretz J., Gobbi L., Ahmed H., Atz K., B&#xfc;rkler M., Bartelmus C., Fingerle J., Guba W., Ullmer C., et al. Structure-Activity Relationship Studies of Pyridine-Based Ligands and Identification of a Fluorinated Derivative for Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors. J. Med. Chem. 2019;62:11165&#x2013;11181. doi: 10.1021/acs.jmedchem.9b01280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jmedchem.9b01280</ArticleId><ArticleId IdType="pubmed">31751140</ArticleId></ArticleIdList></Reference><Reference><Citation>Boutin H., Prenant C., Maroy R., Galea J., Greenhalgh A.D., Smigova A., Cawthorne C., Julyan P., Wilkinson S.M., Banister S.D., et al. [18F]DPA-714: Direct Comparison with [11C]PK11195 in a Model of Cerebral Ischemia in Rats. PLoS ONE. 2013;8 doi: 10.1371/journal.pone.0056441.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0056441</ArticleId><ArticleId IdType="pmc">PMC3572061</ArticleId><ArticleId IdType="pubmed">23418569</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratai E.M., Alshikho M.J., Z&#xfc;rcher N.R., Loggia M.L., Cebulla C.L., Cernasov P., Reynolds B., Fish J., Seth R., Babu S., et al. Integrated imaging of [11C]-PBR28 PET, MR diffusion and magnetic resonance spectroscopy 1H-MRS in amyotrophic lateral sclerosis. NeuroImage Clin. 2018;20:357&#x2013;364. doi: 10.1016/j.nicl.2018.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2018.08.007</ArticleId><ArticleId IdType="pmc">PMC6092554</ArticleId><ArticleId IdType="pubmed">30112276</ArticleId></ArticleIdList></Reference><Reference><Citation>Postnov A., Ahmad R., Evens N., Versijpt J., Vandenbulcke M., Yaqub M., Verbruggen A., Bormans G., Vandenberghe W., Laere K. Quantification of 11C-NE40, a novel PET radioligand for CB2 receptor imaging. J. Nucl. Med. 2013;54:188.</Citation></Reference><Reference><Citation>Slavik R., Herde A.M., Bieri D., Weber M., Schibli R., Kr&#xe4;mer S.D., Ametamey S.M., Mu L. Synthesis, radiolabeling and evaluation of novel 4-oxo-quinoline derivatives as PET tracers for imaging cannabinoid type 2 receptor. Eur. J. Med. Chem. 2015;92:554&#x2013;564. doi: 10.1016/j.ejmech.2015.01.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2015.01.028</ArticleId><ArticleId IdType="pubmed">25599952</ArticleId></ArticleIdList></Reference><Reference><Citation>Territo P.R., Meyer J.A., Peters J.S., Riley A.A., McCarthy B.P., Gao M., Min W., Green M.A., Zheng Q.H., Hutchins G.D. Characterization of 11C-GSK1482160 for Targeting the P2X7 receptor as a biomarker for neuroinflammation. J. Nucl. Med. 2017;58:458&#x2013;465. doi: 10.2967/jnumed.116.181354.</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.116.181354</ArticleId><ArticleId IdType="pubmed">27765863</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan Y.L., Yuan Y., Tian L. Microglial regional heterogeneity and its role in the brain. Mol. Psychiatry. 2020;25:351&#x2013;367. doi: 10.1038/s41380-019-0609-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-019-0609-8</ArticleId><ArticleId IdType="pmc">PMC6974435</ArticleId><ArticleId IdType="pubmed">31772305</ArticleId></ArticleIdList></Reference><Reference><Citation>Farmer W.T., Murai K. Resolving astrocyte heterogeneity in the CNS. Front. Cell. Neurosci. 2017;11 doi: 10.3389/fncel.2017.00300.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2017.00300</ArticleId><ArticleId IdType="pmc">PMC5623685</ArticleId><ArticleId IdType="pubmed">29021743</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques S., Zeisel A., Codeluppi S., Van Bruggen D., Falc&#xe3;o A.M., Xiao L., Li H., H&#xe4;ring M., Hochgerner H., Romanov R.A., et al. Oligodendrocyte heterogeneity in the mouse juvenile and adult central nervous system. Science. 2016;352:1326&#x2013;1329. doi: 10.1126/science.aaf6463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf6463</ArticleId><ArticleId IdType="pmc">PMC5221728</ArticleId><ArticleId IdType="pubmed">27284195</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeisel A., Mu&#xf1;oz-Manchado A.B., Codeluppi S., L&#xf6;nnerberg P., Manno G.L., Jur&#xe9;us A., Marques S., Munguba H., He L., Betsholtz C., et al. Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq. Science. 2015;347:1138&#x2013;1142. doi: 10.1126/science.aaa1934.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa1934</ArticleId><ArticleId IdType="pubmed">25700174</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>